Protocols for Gynecological Cancer
| HIC 0702002345 Thomas Rutherford M.D. Multi-Center, Randomized, Double-Blind, Phase III Efficacy Study Comparing Phenoxodiol in Combination with Carboplatin vs Carboplatin with Placebo in Patients with Platinum-Resistant or Platinum-Refractory Late-Stage Epithelial Ovarian, Fallopian or Prim |
| HIC 0601000992 Peter Schwartz M.D. A randomized parallel group, open label active controlled multicenter phase III trial of patupilone vs pegylated liposomal doxorubicin in taxane/platinum refractory/resistant patients w/recurrent epithelial ovarian, primary fallopian or peritoneal Cancer. |
| HIC 0510000730 Masoud Azodi M.D. A Phase III Trial of Carboplatin & Paclitaxel Plus Placebo vs Carboplatin & Paclitaxel Plus Concurrent Bevacizumab (NSC #704865, IND #7921) Followed by Placebo, vs Carboplatin & Paclitaxel Plus Concurrent & Extended Bevacizumab, in Women w/newly (GOG 0218 |
| HIC 27640 Thomas Rutherford M.D. A Randomized Placebo-Controlled Phase Ib/IIa Safety, Tolerability And Efficacy Study Of Oral Phenoxodiol In Combination With Docetaxel Versus Docetaxel Alone In Patients With Recurrent Epithelial Ovarian, Fallopian Tube And Primary Peritoneal Cancer |
| HIC 0510000732 Joanne Weidhaas M.D.;Ph.D. A Phase III, Randomized Trial of Weekly Cisplatin and Radiation Versus Cisplatin and Tirapazamine and Radiation in Stage IB2, IIA, IIIB and IVA Cervical Carcinoma Limited to the Pelvis (GOG 0219) |
| HIC 0705002665 Peter Schwartz M.D. (GOG 0212) A Randomized Phase III Trial of Maintenance Chemotherapy Comparing 12, Monthly Cycles of Single Agent Paclitaxel or Xyotax (CT-2103) (IND # 70177) versus No Treatment Until Documented Relapse in Women with Advanced Ovarian or Primary Peritoneal |
| HIC 26316 Masoud Azodi M.D. Phase Ib Safety And Efficacy Study Of Neoadjuvant Use Of Oral Phenoxodiol In Patients With Primary Diagnosis Of Squamous Cell Carcinoma And Adenocarcinoma Of The Cervix, Vagina Or Vulva |
| HIC 0507000414 Peter Schwartz M.D. A Phase II Study Of AP23573, a mTOR Inhibitor, In Female Adult Patients With Recurrent Or Persistent Endometrial Cancer AP23573-04-203 |
| HIC 27493 Susan Higgins M.D. A Phase II Trial Of Radiation Therapy And Weekly Cisplatin Chemotherapy for the Treatment of Locally-Advanced Squamous Cell Carcinoma of the Vulva (GOG 0205) |
| HIC 0710003201 Peter Schwartz M.D. A Phase II Randomized Study of the Effect of Zoledronic Acid vs Observation on Bone Mineral Density of the Lumbar Spine in Women who Elect to Undergo Risk-Reducing Surgery that Results in Removal of Both Ovaries (GOG 0215) |
| HIC 0702002344 Thomas Rutherford M.D. A Phase II, Multicenter, Randomized, Blinded, Placebo-Controlled Trial of Carboplatin and Gemcitabine Plus Bevacizumab in Patients with Platinum-Sensitive Recurrent Ovary, Primary Peritoneal, or Fallopian Tube Carcinoma |